Skip to Content

SEC Filings

Filing date	Form	Description	View
Apr 08, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-010517.pdf 0000899243-20-010517.rtf 0000899243-20-010517.xls View HTML
Apr 08, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-010518.pdf 0000899243-20-010518.rtf 0000899243-20-010518.xls View HTML
Apr 10, 2020	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-20-103890.pdf 0001193125-20-103890.rtf 0001193125-20-103890.xls View HTML
Apr 22, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-011148.pdf 0000899243-20-011148.rtf 0000899243-20-011148.xls View HTML
Apr 22, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-011149.pdf 0000899243-20-011149.rtf 0000899243-20-011149.xls View HTML
Apr 22, 2020	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-20-115075.pdf 0001193125-20-115075.rtf 0001193125-20-115075.xls View HTML
May 07, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-20-022829.pdf 0001564590-20-022829.rtf 0001564590-20-022829.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
May 28, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-154365.pdf 0001193125-20-154365.rtf 0001193125-20-154365.xls View HTML
Jul 24, 2020	SC 13D/A	An amendment to a SC 13D filing	0001193125-20-197975.pdf 0001193125-20-197975.rtf 0001193125-20-197975.xls View HTML
Jul 24, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-020428.pdf 0000899243-20-020428.rtf 0000899243-20-020428.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2024 Merrimack Pharmaceuticals.